Representing Kansas bioscience companies and research institutions
Home About KansasBio Membership Center Bioscience News Contact KansasBio
Information Resources Education & Training Networking & Collaboration Business & Investment


Up-to-the minute latest news in the biotechnology sector and from biotech companies in Kansas and around the world

  KansasBio photos  


Biotechnology Headlines from PR Newswire

Adheris Health, Behavioral Insights Group Launches Next Phase Of Ethnographic Study To Help Healthcare Companies Effectively Engage With American Families
Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma
Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors
Xyntek and Antares Serialization Solution Protects Pets Too!
Profectus BioSciences Receives Department of the Army Funding for Studies Directed Toward the Development of a VesiculoVax™ rVSV-Vectored Vaccine for Ebola and Marburg Viruses
Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin
Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin
Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes
Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020
Report: Radical New IVD Test Approaches Key To Growth
Expanding Orthopedics Inc. Granted a New US patent - Adding to its Extensive IP Portfolio of Expandable Bone Devices
aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research
Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020)
Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc.
Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders
iCo Therapeutics Announces Advancement of Oral Amphotericin B Program
Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program
Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise
Elsevier Launches First Virtualized Medical Institution on PracticeUpdate
Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets
Johnson & Johnson Announces Major Commitment to Speed Ebola Vaccine Development and Significantly Expand Production
Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate
Cumberland Pharmaceuticals To Announce Third Quarter 2014 Financial Results On November 4, 2014
Amgen Statement Regarding Third Point Investment
Tianyin Pharmaceutical Received Notices of Non-Compliance from NYSE MKT
BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation
Global Dental Bone Graft Substitutes and other Biomaterials Market (Natural, Ceramic, Composite and Polymer) - Forecast to 2020
David and Barbara Roux Provide Historic $10 Million Gift to Advance Genomic Medicine Research at The Jackson Laboratory
UCSF Medical Center Adopts Hi-Tech "Smart" Dressing for Chronic Wounds
Uncommon Vision: A Conversation with Ophthalmologist, Entrepreneur and Investor Jack Kavanaugh
Generex Announces Publication of Ebola Vaccine White Paper by Antigen Express
Technical Data on Biotech Equities - Intrexon, Keryx Biopharma, Spectrum Pharma, Sangamo BioSciences, and Cubist Pharma
Metabolix to Conduct Webcast of Its Third Quarter Fiscal Year 2014 Earnings Call
BioClinica Announces User Conferences in Europe and US
MabVax Therapeutics Nominates The Fully Human Antibody HuMab 5B1 As The Company's Lead Clinical Development Candidate
SRI International Opens Clinical Trial Unit in Michigan Life Science Innovation Center
TWi Biotechnology Receives Orphan Drug Designation for its Lead Drug Candidate AC-201 in United States
Automated EEG Biofeedback Proven Effective in Addiction Treatment
TrialScope Appoints Richard Aguinaldo as Chief Financial Officer
Bio-Techne To Host Conference Call On October 28, 2014 To Announce First Quarter Financial Results
BioSpecifics Technologies Corp. Announces FDA Approval of sBLA for XIAFLEX® for the Concurrent Treatment of Two Dupuytren's Contracture Cords
Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO English English English
First Patient Successfully Implanted in Safety/Efficacy Study of Beta-O2's ßAir Bio-Artificial Pancreas for Type 1 Diabetes
Sequenom, Inc. Announces Date Of Third Quarter 2014 Financial Results And Conference Call
Sinovac to Participate in Jefferies 4th Annual Asia Summit
RoosterBio Selects BioLife Solutions CryoStor® to Commercialize Human Bone Marrow-Derived Stem Cells
Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bacteria
Marken Expands Cold Chain Capacity To Meet Growing Demand
United Therapeutics Corporation To Announce Third Quarter 2014 Financial Results Before Market Open On Tuesday, October 28, 2014
China Heparin Industry 2014-2017 Report Forecasts Chinese Heparin API Market to Account Roughly 80% of Global Demand

< Prev Next >
PR Newswire - United Business Media

Kansas Bioscience Association

© 2004 Kansas Bioscience Organization (KansasBio). All rights reserved.